PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,774 | -65.0% | 226,268 | -42.0% | 0.01% | -62.5% |
Q2 2023 | $10,779 | -32.2% | 390,267 | -43.5% | 0.02% | -23.8% |
Q1 2023 | $15,890 | +462.7% | 690,867 | +166.9% | 0.02% | +425.0% |
Q4 2022 | $2,824 | -99.9% | 258,867 | -35.2% | 0.00% | -20.0% |
Q3 2022 | $3,370,000 | +31.9% | 399,767 | +23.8% | 0.01% | +66.7% |
Q2 2022 | $2,554,000 | +454.0% | 322,867 | +1558.5% | 0.00% | +200.0% |
Q1 2022 | $461,000 | -36.1% | 19,467 | -45.6% | 0.00% | 0.0% |
Q4 2020 | $722,000 | -89.0% | 35,797 | -89.4% | 0.00% | -85.7% |
Q3 2020 | $6,582,000 | -30.0% | 336,700 | -36.7% | 0.01% | -12.5% |
Q2 2020 | $9,400,000 | +131.4% | 532,300 | -7.5% | 0.01% | +100.0% |
Q1 2020 | $4,062,000 | -6.8% | 575,400 | -6.9% | 0.00% | +33.3% |
Q4 2019 | $4,358,000 | -34.6% | 618,124 | +11.4% | 0.00% | -50.0% |
Q3 2019 | $6,667,000 | +7.5% | 555,100 | +8.4% | 0.01% | +20.0% |
Q2 2019 | $6,204,000 | +21.9% | 512,300 | +26.5% | 0.01% | 0.0% |
Q1 2019 | $5,091,000 | +122.6% | 405,000 | +19.2% | 0.01% | +66.7% |
Q4 2018 | $2,287,000 | -58.6% | 339,800 | -36.7% | 0.00% | -50.0% |
Q3 2018 | $5,528,000 | +51.0% | 537,200 | +1.3% | 0.01% | +200.0% |
Q2 2018 | $3,662,000 | +717.4% | 530,500 | +916.3% | 0.00% | – |
Q1 2018 | $448,000 | +52.4% | 52,200 | +100.9% | 0.00% | – |
Q2 2017 | $294,000 | – | 25,989 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |